Graham, David J <br/><br/>
Troglitazone-induced liver failure: a case study.  [electronic resource] 

 -  The American journal of medicine  Mar 2003 
 - 299-306 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0002-9343 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9343(02)01529-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Distribution<br/>Aged<br/>Chemical and Drug Induced Liver Injury--epidemiology<br/>Chromans--administration & dosage<br/>Chronic Disease<br/>Confidence Intervals<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dose-Response Relationship, Drug<br/>Drug and Narcotic Control<br/>Female<br/>Humans<br/>Liver Failure--chemically induced<br/>Liver Failure, Acute--chemically induced<br/>Liver Function Tests<br/>Male<br/>Middle Aged<br/>Odds Ratio<br/>Probability<br/>Registries<br/>Risk Assessment<br/>Severity of Illness Index<br/>Sex Distribution<br/>Survival Rate<br/>Thiazoles--administration & dosage<br/>Thiazolidinediones<br/>Troglitazone<br/>United States<br/>United States Food and Drug Administration